[Tree] Higher health care costs for employers in 2024, legal issues with prescription drug benefits plans, new weight-loss drug from Amgen, Medicare drug price negotiations, hospitals pushing back against site-neutral payment rules, key trends shaping health benefits and costs, cyberattack on UnitedHealth's Change Healthcare, SECURE 2.0 law offering tax credits for retirement benefits, building a culture of appreciation in the workplace, employee benefits in a challenging economy, HIPAA privacy rights for reproductive health care
Version 0.1 (2024-06-19 19:32:31.852000)
updates: Enhanced HIPAA privacy rights for reproductive health care
- ➔
- ➔
- ➔
Version 0.09 (2024-06-11 10:53:19.603000)
updates: Information about the financial stress of employees and the benefits of on-demand pay
- ➔
- ➔
- ➔
Version 0.08 (2024-06-06 10:55:55.032000)
updates: Information about the impact of the challenging economy on employees and the importance of financial wellness and on-demand pay as employee benefits [ccfe0db3]
- ➔
- ➔
- ➔
Version 0.07 (2024-05-31 08:55:31.749000)
updates: Added information about the challenges of employee benefits in a challenging economy
- ➔
- ➔
- ➔
Version 0.06 (2024-04-07 12:21:07.132000)
updates: Legal risks and direct contracting with providers pose challenges for employers
- ➔
- ➔
Version 0.05 (2024-02-29 16:30:48.084000)
updates: Updates on health care costs for employers in 2024, legal issues with prescription drug benefits plans, new weight-loss drug from Amgen, Medicare drug price negotiations, hospitals pushing back against site-neutral payment rules, key trends shaping health benefits and costs, cyberattack on UnitedHealth's Change Healthcare, SECURE 2.0 law offering tax credits for retirement benefits, building a culture of appreciation in the workplace
- ➔
Version 0.04 (2024-02-29 05:16:39.461000)
updates: Bipartisan bill introduced to address disparity in drug negotiation periods for biologics and small molecules
- ➔
- ➔
Version 0.03 (2024-02-17 18:17:30.153000)
updates: Integration of information on corporate greed in the pharmaceutical industry and high drug prices
- ➔
- ➔
Version 0.02 (2024-02-07 16:13:10.155000)
updates: Medicare initiates negotiations with drugmakers over expensive medications
- ➔
Version 0.01 (2023-12-30 11:04:22.602000)
updates: Added information about concerns regarding the long-term stability and solvency of Medicare
- ➔